CYDY · CytoDyn Inc.
$0.25
+0.01 (+3.67%)
At close · Aug 26
Going-concern doubt
— flagged Apr 8, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors, among others, including the various matters discussed in Note 10, *Commitments and Contingencies*, raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Apr 8, 2026
Market Cap
$327.85M
Shares
1.37B
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
No Buyback Data
This company's XBRL filings report no share-repurchase activity yet.